Literature DB >> 20423622

[Short form of the WAIS-III for use with patients with schizophrenia].

Inmaculada Fuentes Durá1, María Romero Peris, Carmen Dasí Vivó, Juan Carlos Ruiz Ruiz.   

Abstract

The aim of this study is to obtain a sufficiently guaranteed, abridged, Spanish version of the WAIS-III and thereby reduce the time needed to administer the complete scale. Although the samples used were based both on normal individuals (41 participants with no known history of mental illness) as well as individuals diagnosed with schizophrenia (41 participants), the real focus of the study was the clinical group because this is where the greatest advantages can be obtained by shortening the time to administer the scale. The data demonstrates that the best combination of tests was: Similarities, Picture Completion, Digit Span and Digit Symbol-coding because, with this reduced form, it was possible to obtain a linear correlation between the IQ of the complete scale and that of the abridged form of .91 in the clinical and .86 in the control group. For both groups, the differences between the real IQ averages and the estimated ones were nonsignificant.

Entities:  

Mesh:

Year:  2010        PMID: 20423622

Source DB:  PubMed          Journal:  Psicothema        ISSN: 0214-9915


  2 in total

1.  Search for schizophrenia and bipolar biotypes using functional network properties.

Authors:  Inés Fernández-Linsenbarth; Álvaro Planchuelo-Gómez; Rosa M Beño-Ruiz-de-la-Sierra; Alvaro Díez; Antonio Arjona; Adela Pérez; Alberto Rodríguez-Lorenzana; Pilar Del Valle; Rodrigo de Luis-García; Guido Mascialino; Pedro Holgado-Madera; Rafael Segarra-Echevarría; Javier Gomez-Pilar; Pablo Núñez; Berta Bote-Boneaechea; Antonio Zambrana-Gómez; Alejandro Roig-Herrero; Vicente Molina
Journal:  Brain Behav       Date:  2021-11-10       Impact factor: 2.708

2.  Anomalous self-experiences are related to general cognition deficits in schizophrenia.

Authors:  Marta Hernández-García; Marta Gómez-García; Eva Sotelo; Inés Fernández-Linsenbarth; Pilar Andrés-Olivera; Rubén de Alarcon-Gómez; María Fe Muñoz-Moreno; Vicente Molina
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-11-22       Impact factor: 5.270

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.